Trial site
Seoul
- 10running trials
- 9closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Asthma4 trials
- COPD3 trials
- Gastric and oesophageal cancer2 trials
- Multiple myeloma2 trials
- Multiple sclerosis2 trials
- Atopic dermatitis (eczema)1 trial
- Chronic rhinosinusitis with nasal polyps1 trial
- Colorectal cancer1 trial
- Haemophilia1 trial
- Hidradenitis suppurativa1 trial
- Liver and biliary tract cancer1 trial
- Metastatic breast cancer1 trial
- Phase
- Phase 38 trials
- Phase 27 trials
- Phase 42 trials
- Phase 1/21 trial
- Status
- Active, not recruiting6 trials
- Completed6 trials
- Recruiting3 trials
- Terminated3 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Sanofi18 trials
- Genzyme, a Sanofi Company1 trial
Running trials
Recruiting
Recruiting
Active, not recruiting
Enrolling by invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
Active, not recruiting
Observational Evaluation of Atopic Dermatitis in Pediatric Patients
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- COPD2 recruiting
- Asthma1 recruiting
- Multiple myeloma1 recruiting
Closed trials
Completed
Terminated
Completed
Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe Asthma
Completed
Terminated
Completed
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026